EBR Systems Seeks ASX Quotation for Additional CDIs

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) just unveiled an update.

EBR Systems, Inc., a medical technology company specializing in cardiac pacing solutions for heart rhythm disorders, continues to build out its capital structure as it advances its product and market strategy within the cardiac device sector. The company targets patients requiring sophisticated pacing therapies, positioning itself in a niche segment of the broader cardiovascular technology market.

The company has applied for quotation on the ASX of 109,100 new CHESS Depositary Interests (CDIs) on a 1:1 basis, issued on March 24, 2026, under the code EBR. The additional securities, which exclude U.S. persons other than qualified institutional buyers, modestly expand the company’s tradable float and may slightly enhance liquidity for existing investors on the Australian market.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.47 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a medical technology company focused on developing and commercializing cardiac pacing solutions. Its products are designed to treat patients with heart rhythm disorders, targeting the advanced cardiac device market through innovative leadless pacing systems.

Average Trading Volume: 499,849

Technical Sentiment Signal: Sell

Current Market Cap: A$301.7M

For an in-depth examination of EBR stock, go to TipRanks’ Overview page.